KEYTRUDA: CURE FOR ADVANCED ENDOMETRIAL CANCER?
1 Views
administrator
07/17/23
Endometrial cancer, or cancer of the lining of the uterus, is the second most common form of cancer in women worldwide. When surgery and chemotherapy don’t work, the five-year survival rate is just 17 percent. Now, there’s an FDA-approved immunotherapy that experts say may be life-changing for women with advanced endometrial cancer.
-
Category
Show more
Facebook Comments
No comments found